Viatris Introduces Effexor® in Japan as Innovative Treatment for GAD Viatris has secured approval from Japan's Ministry of Health for Effexor® SR, addressing substantial unmet needs for GAD treatment.

Viatris Introduces Effexor® in Japan as Innovative Treatment for GAD #Japan #Tokyo #Viatris #EFFEXOR® #GAD

Viatris Unveils Strategic Vision for Sustainable Growth Through 2030 Viatris Inc. presents its strategic roadmap aimed at achieving sustained revenue and earnings growth by 2030, focusing on a robust product portfolio and innovative pipeline.

Viatris Unveils Strategic Vision for Sustainable Growth Through 2030 #United_States #Pittsburgh #pharmaceuticals #Business_Growth #Viatris

Viatris Board Approves 2026 Dividend Policy and Quarterly Payment Details Viatris Inc. has approved its 2026 dividend policy, maintaining a payment of 48 cents per share. Quarterly dividends will be continued for shareholders, reinforcing the company’s commitment.

Viatris Board Approves 2026 Dividend Policy and Quarterly Payment Details #healthcare #US #dividends #Pittsburgh #Viatris

FDA Accepts MR-141 for Presbyopia Treatment, A Milestone for Viatris Viatris proudly announces FDA acceptance of its MR-141 drug application for treating presbyopia, a significant step forward.

FDA Accepts MR-141 for Presbyopia Treatment, A Milestone for Viatris #United_States #Pittsburgh #Viatris #presbyopia #MR-141

Viatris Appoints Matthew J. Maletta as New Chief Legal Officer Amid Transition Matthew J. Maletta has been named Chief Legal Officer at Viatris, ensuring smooth leadership transition after Brian Roman's 20 years of service.

Viatris Appoints Matthew J. Maletta as New Chief Legal Officer Amid Transition #United_States #Pittsburgh #Viatris #Matthew_Maletta #Brian_Roman

Viatris Launches Inpefa®: A Groundbreaking Treatment for Heart Failure in UAE Viatris Inc. unveils Inpefa® (sotagliflozin) in UAE, marking its first step in a global expansion of this innovative treatment for heart failure.

Viatris Launches Inpefa®: A Groundbreaking Treatment for Heart Failure in UAE #United_Arab_Emirates #Dubai #Viatris #Inpefa #Sotagliflozin

Viatris Names Lara Ramsburg as Chief People and Corporate Affairs Officer Viatris has appointed Lara Ramsburg as the Chief People and Corporate Affairs Officer, aiming to enhance communication strategies and culture.

Viatris Names Lara Ramsburg as Chief People and Corporate Affairs Officer #United_States #Pittsburgh #Corporate_Affairs #Viatris #Lara_Ramsburg

Viatris Announces Regulatory Milestones Across its Drug Pipeline for 2025 Viatris Inc. reveals significant regulatory achievements, including FDA approvals and new applications for several important medications, underscoring its commitment to healthcare innovation.

Viatris Announces Regulatory Milestones Across its Drug Pipeline for 2025 #United_States #Pittsburgh #FDA_Approvals #Viatris #drug_pipeline

Viatris Takes Strategic Step by Selling Stake in Biocon Biologics Limited Viatris Inc. has finalized agreements with Biocon Limited to sell its stake in Biocon Biologics. This strategic move is set to redefine their market position and growth opportunities.

Viatris Takes Strategic Step by Selling Stake in Biocon Biologics Limited #None #healthcare #Biocon_Biologics #Viatris

Prevenzione maschile: come si comportano gli uomini italiani secondo la ricerca di Viatris Novembre è il mese della prevenzione maschile, un’occasione dedicata alla sensibilizzazione sulla salute dell’uomo, dai controlli della prostata al benessere sessuale

Novembre è il mese della prevenzione maschile, un’occasione dedicata alla sensibilizzazione sulla salute dell’uomo, dai controlli della prostata al benessere sessuale #benessere-sessuale #emmanuele-jannini #fabio-torriglia #prevenzione-maschile #viatris

Viatris Announces Participation at Two Key Healthcare Investor Conferences in December 2025 Viatris Inc. will participate in significant healthcare conferences in December 2025, featuring live fireside chats. Investors can tune in for insights.

Viatris Announces Participation at Two Key Healthcare Investor Conferences in December 2025 #United_States #healthcare #Pittsburgh #investor_conference #Viatris

The Impact of Rising Costs and Declining Antibiotic Prices on Healthcare Access in Europe A recent study by Viatris and Medicines for Europe reveals alarming trends in antibiotic pricing and availability, urging immediate reforms to ensure sustainable access to essential medicines.

The Impact of Rising Costs and Declining Antibiotic Prices on Healthcare Access in Europe #None #Antibiotics #Viatris #Medicines_for_Europe

Decline in Antibiotic Prices Amid Rising Costs and Shortages in Europe A recent independent study reveals alarming trends in antibiotic pricing and supply shortages, stressing the need for urgent policy reform to ensure accessibility.

Decline in Antibiotic Prices Amid Rising Costs and Shortages in Europe #None #Antibiotics #Viatris #Medicines_for_Europe

European Study Unveils Price Drops Amid Rising Production Costs and Drug Shortages A recent independent study reveals that while essential antibiotic prices are declining, production costs are soaring, leading to critical shortages. Urgent reforms are needed.

European Study Unveils Price Drops Amid Rising Production Costs and Drug Shortages #France #Brussels #AMR #Viatris #Medicines_for_Europe

European Study Reveals Falling Prices and Rising Costs Amid Antibiotic Shortages During World AMR Week A recent European study highlights the critical shortages of off-patent antibiotics, revealing the disconnect between falling prices and rising production costs amid the World AMR Awareness Week.

European Study Reveals Falling Prices and Rising Costs Amid Antibiotic Shortages During World AMR Week #None #AMR #Viatris #Medicines_for_Europe

Research Highlights Declining Antibiotic Prices Amid Rising Production Costs in Europe A recent report reveals worrying trends in Europe's antibiotic market, showcasing falling prices against a backdrop of rising production costs and shortages.

Research Highlights Declining Antibiotic Prices Amid Rising Production Costs in Europe #None #Brussels #Viatris #Medicines_for_Europe #Antibiotic_Access

European Study Reveals Decreasing Prices and Increasing Costs for Essential Medicines A new report highlights the urgent need for policy reforms in Europe to ensure sustainable access to essential, off-patent medicines amidst rising production costs and decreasing prices.

European Study Reveals Decreasing Prices and Increasing Costs for Essential Medicines #None #AMR #Viatris #Medicines_for_Europe

European Study Highlights Decreasing Prices and Growing Shortages in Antibiotics Amid Rising Costs The recent European study reveals significant issues in the pharmaceutical sector, particularly concerning antibiotic availability, cost inflation, and urgent reforms needed to ensure healthcare access.

European Study Highlights Decreasing Prices and Growing Shortages in Antibiotics Amid Rising Costs #Brussels #Czech_Republic #AMR #Viatris #Medicines_for_Europe

Understanding the Impact of Antimicrobial Resistance: A Call for Urgent Policy Reform As World AMR Awareness Week unfolds, an independent study highlights the troubling trends in antibiotic availability and calls for urgent reforms in pricing and procurement.

Understanding the Impact of Antimicrobial Resistance: A Call for Urgent Policy Reform #Brussels #Belgium #Antimicrobial_Resistance #Viatris #Medicines_for_Europe

Viatris Reveals Q3 2025 Financial Success, Ups Financial Outlook Viatris reports strong Q3 2025 results with total revenues matching expectations. Key acquisitions and pipeline updates highlight continued growth.

Viatris Reveals Q3 2025 Financial Success, Ups Financial Outlook #United_States #Pittsburgh #Business_Performance #Viatris #Financial_Update

Viatrisがアキュリスファーマを完全子会社化、革新的医薬品の開発強化へ Viatrisがアキュリスファーマを完全子会社化し、日本における中枢神経系治療薬の展開を強化。新たな治療薬の市場導入に期待が寄せられています。

Viatrisがアキュリスファーマを完全子会社化、革新的医薬品の開発強化へ #医薬品 #アキュリスファーマ #Viatris

Viatrisがアキュリスファーマを完全子会社化し、日本における中枢神経系治療薬の展開を強化。新たな治療薬の市場導入に期待が寄せられています。

Starting the day at #Viatris

#ps25uk #pharmacyshow

Calling out #AMR
#Viatris #ps25uk #pharmacyshow

Hey, if you are at the #ps25uk #pharmacyshow today, then do have a look at the #Viatris session on their stand.

I've just sat in on the UTI Pharmacy First session, and frankly it was well delivered and an amazing speaker.

Are you using the NEWS2 score when initiating those UTI consultations?

#Viatris
#ps25uk #pharmacyshow

Viatris Earns Spot on Forbes' Best Employers List for 2025: A Testament to Commitment For the fifth consecutive year, Viatris has been recognized by Forbes as one of the World's Best Employers. This accolade highlights the company's focus on employee well-being and inclusivity.

Viatris Earns Spot on Forbes' Best Employers List for 2025: A Testament to Commitment #USA #Forbes #Pittsburgh #Best_Employers #Viatris

www.forbes.com/companies/my...
#Mylan #Viatris

Salute, per il Mese della consapevolezza del dolore torna la campagna di sensibilizzazione (Adnkronos) - In occasione del Mese della consapevolezza del dolore, che si celebra a settembre, Viatris Italia, azienda del gruppo Viatris, una realtà globale che opera nell'ambito della salute, rinnova il proprio impegno nel sensibil...

Salute, per il Mese della consapevolezza del dolore torna la campagna di sensibilizzazione ... LEGGI TUTTO #MeseDellaConsapevolezzaDelDolore #Salute #Viatris #CampagnaDiSensibilizzazione #Dolore

Viatris ottiene la certificazione Great Place to Work in Italia “Questa certificazione rappresenta la conferma di quanto le persone siano al centro", ha detto Monica Ardielli, head of hr di Viatris Italia

“Questa certificazione rappresenta la conferma di quanto le persone siano al centro", ha detto Monica Ardielli, head of hr di #Viatris Italia

Viatris Welcomes Andrew Enrietti as Chief Administrative Officer for Transformation Viatris has appointed Andrew Enrietti as Chief Administrative and Transformation Officer to drive the company's strategic evolution and growth.

Viatris Welcomes Andrew Enrietti as Chief Administrative Officer for Transformation #United_States #healthcare #Pittsburgh #Viatris #Andrew_Enrietti